World's Best Scientists 2026 revealed!
Richard N. Greenberg

Richard N. Greenberg

D-Index & Metrics

Biology and Biochemistry

D-Index
57
Citations
16472
World Ranking
13599
National Ranking
5768

Richard N. Greenberg publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Richard N. Greenberg sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 147 publications — 25th percentile

25% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Richard N. Greenberg D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Richard N. Greenberg sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 57 D-Index — 31st percentile

31% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Richard N. Greenberg is affiliated with the University of Kentucky in the United States and has contributed to the field of medicine, with a focus on infectious diseases, epidemiology, virology, molecular biology, and health. Their research topics cover a range of subjects related to infectious diseases and public health, including SARS-CoV-2 and COVID-19 research, poxvirus outbreaks, bacterial research on Bacillus and Francisella, vaccine coverage and hesitancy, clinical research on COVID-19, pneumonia, respiratory infections, and sepsis diagnosis and treatment.

Among the recent papers authored or co-authored by this researcher are:

  • Equivalence of freeze-dried and liquid-frozen formulations of MVA-BN as smallpox and mpox vaccine, 2024, Human Vaccines & Immunotherapeutics
  • Low-dose methylprednisolone treatment in critically ill patients with severe community-acquired pneumonia, 2022, Intensive Care Medicine
  • Systemic antifungal therapy with isavuconazonium sulfate or other agents in adults with invasive mucormycosis or invasive aspergillosis (non-fumigatus): A multicentre, non-interventional registry study, 2021, Mycoses
  • Efficacy of Messenger RNA-1273 Against Severe Acute Respiratory Syndrome Coronavirus 2 Acquisition in Young Adults From March to December 2021, 2023, Open Forum Infectious Diseases
  • Erratum to: Non-nucleoside reverse transcriptase inhibitor efavirenz activates PXR to induce hypercholesterolemia and hepatic steatosis [J Hepatol (2019); 70 (5): 930-940], 2021, Journal of Hepatology

Frequent co-authors in their research include:

  • Thomas J. Martin
  • Nitin Seam
  • Antonio Anzueto
  • Peruvemba Sriram
  • Charlie Lan

Their work has been published in several distinct scientific venues, indicating a broad interdisciplinary reach in the medical and health sciences fields. These publication venues include:

  • Intensive Care Medicine
  • Human Vaccines & Immunotherapeutics
  • Mycoses
  • Open Forum Infectious Diseases
  • Journal of Hepatology

Richard N. Greenberg's research addresses critical aspects of infectious disease management, vaccine efficacy, and treatment protocols. The body of work demonstrates involvement in both clinical research studies and broader epidemiological investigations. This includes notable research on treatments for severe pneumonia, vaccine development for viral pathogens, as well as antifungal therapies for invasive infections.

Best Publications

  • A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults.

    M. N. Oxman;M. N. Oxman;M. J. Levin;G. R. Johnson;K. E. Schmader

  • Liposomal Amphotericin B for Empirical Therapy in Patients with Persistent Fever and Neutropenia

    Thomas J. Walsh;Robert W. Finberg;Carola Arndt;John Hiemenz

  • Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever

    Thomas J. Walsh;Peter Pappas;Drew J. Winston;Hillard M. Lazarus

  • A Randomized Placebo-Controlled Trial of Saccharomyces boulardii in Combination With Standard Antibiotics for Clostridium difficile Disease

    Lynne V. McFarland;Christina M. Surawicz;Richard N. Greenberg;Robert Fekety

  • Voriconazole Treatment for Less-Common, Emerging, or Refractory Fungal Infections

    John R. Perfect;Kieren A. Marr;Thomas J. Walsh;Richard N. Greenberg

  • The Search for a Better Treatment for Recurrent Clostridium difficile Disease: Use of High-Dose Vancomycin Combined with Saccharomyces boulardii

    Christina M. Surawicz;Lynne V. McFarland;Richard N. Greenberg;Moshe Rubin

  • Posaconazole as salvage therapy for zygomycosis

    R. N. Greenberg;R. N. Greenberg;K. Mullane;J. A H Van Burik;I. Raad

  • Recurrent Clostridium difficile diarrhea: characteristics of and risk factors for patients enrolled in a prospective, randomized, double-blinded trial.

    Robert Fekety;Lynne V. McFarland;Christina M. Surawicz;Richard N. Greenberg

  • Recurrent Clostridium difficile disease : Epidemiology and clinical characteristics

    Lynne V. McFarland;Christina M. Surawicz;Moshe Rubin;Robert Fekety

  • Phase II trial of 96-hour paclitaxel plus oral estramustine phosphate in metastatic hormone-refractory prostate cancer.

    Gary R. Hudes;Faith Nathan;Christina Khater;Naomi Haas

  • Phase II study of estramustine and vinblastine, two microtubule inhibitors, in hormone-refractory prostate cancer.

    G R Hudes;R Greenberg;R L Krigel;S Fox

  • Zygomycosis (mucormycosis): emerging clinical importance and new treatments

    Richard N Greenberg;Lauren J Scott;Heather H Vaughn;Julie A Ribes

  • Safety of long-term oral posaconazole use in the treatment of refractory invasive fungal infections.

    Issam I. Raad;John R. Graybill;Ana Beatriz Bustamante;Oliver A. Cornely

  • Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine in adults 70 years of age and older previously vaccinated with 23-valent pneumococcal polysaccharide vaccine

    Lisa A. Jackson;Alejandra Gurtman;Kathryn Rice;Karlis Pauksens

  • HIV protease inhibitors promote atherosclerotic lesion formation independent of dyslipidemia by increasing CD36-dependent cholesteryl ester accumulation in macrophages

    James Dressman;Jeanie Kincer;Sergey V. Matveev;Ling Guo

  • Safety and immunogenicity of an oral, replicating adenovirus serotype 4 vector vaccine for H5N1 influenza: a randomised, double-blind, placebo-controlled, phase 1 study

    Marc Gurwith;Michael Lock;Eve M Taylor;Glenn Ishioka

  • Pharmacoeconomic Analysis of Liposomal Amphotericin B Versus Conventional Amphotericin B in the Empirical Treatment of Persistently Febrile Neutropenic Patients

    Pablo J. Cagnoni;Thomas J. Walsh;Mary M. Prendergast;David Bodensteiner

  • Sequential administration of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine in pneumococcal vaccine–naïve adults 60–64 years of age

    Richard N. Greenberg;Alejandra Gurtman;Robert W. Frenck;Cynthia Strout

  • Comparison of effects of uroguanylin, guanylin, and Escherichia coli heat-stable enterotoxin STa in mouse intestine and kidney: evidence that uroguanylin is an intestinal natriuretic hormone.

    Richard N. Greenberg;Michael Hill;Jessica Crytzer;William J. Krause

  • IMVAMUNE: modified vaccinia Ankara strain as an attenuated smallpox vaccine.

    Jeffrey S Kennedy;Richard N Greenberg

Frequent Co-Authors

Robert G. Uzzo
Robert G. Uzzo Fox Chase Cancer Center
David D. Y. Chen
David D. Y. Chen University of British Columbia
Avindra Nath
Avindra Nath National Institutes of Health
Michael S. Simberkoff
Michael S. Simberkoff New York University
Myron J. Levin
Myron J. Levin University of Colorado Anschutz Medical Campus
Peter G. Pappas
Peter G. Pappas University of Alabama at Birmingham
Michael N. Oxman
Michael N. Oxman University of California, San Diego
Robert D. Arbeit
Robert D. Arbeit Tufts University
Kenneth E. Schmader
Kenneth E. Schmader Duke University
Marie R. Griffin
Marie R. Griffin Vanderbilt University Medical Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Biology and Biochemistry unlocks a wide range of online degree options and career pathways in the health and science sectors. If you’re interested in leadership and administration within healthcare, doctoral programs for healthcare administration can prepare you for senior roles in hospitals, health systems, or public policy.

For those drawn to pharmaceuticals and medication management, online pharmacy schools provide advanced training and open doors to careers as pharmacists, clinical researchers, or pharmaceutical consultants.

Interested in health, fitness, or wellness? An online exercise science degree combines biology with applied science, leading to professions in athletic training, wellness coaching, or rehabilitation.

Additionally, online kinesiology degrees focus on human movement. These programs are great for those aiming to work in physical therapy, sports performance, or occupational health.

Together, these related online degrees offer flexible learning options and a variety of rewarding career pathways—all rooted in a strong foundation in Biology and Biochemistry.

Best Scientists Citing Richard N. Greenberg

Trending Scientists

Recently Published Articles